Table 1. Patient characteristics.
| N | 43 |
| Median age (IQR)—years | 73 (65–79) |
| Sex—no. of women (%) | 21 (48.8) |
| Hemisphere—no. of left (%) | 24 (55.8) |
| Premorbid mRS—no. (%) | |
| 0 | 22 (51.2) |
| 1 | 9 (20.9) |
| 2 | 7 (16.3) |
| 3 | 3 (7) |
| 4 | 1 (2.3) |
| Risk factor status (on admission)—no. (%) | |
| Atrial fibrillation | 23 (53.5) |
| Coronary heart disease | 16 (37.2) |
| Congestive heart failure | 4 (9.3) |
| Arterial hypertension | 38 (88.4) |
| Diabetes mellitus | 11 (25.6) |
| Glucose (mg/dL) | 125 (30) |
| Current smoking | 9 (20.9) |
| Hyperlipidemia | 20 (46.5) |
| Median NIHSS on admission (IQR) | 19 (15–20.25) |
| Vessel occlusion—no. (%) | |
| M1 | 20 (46.5) |
| ICA + M1 | 18 (41.9) |
| M1 + M2 | 2 (4.7) |
| M2 | 1 (2.3) |
| Intravenous rtPA—no. (%) | 29 (67.4) |
| Intraarterial rtPA—no. (%) | 8 (18.6) |
| Reperfusion result (TICI)—no. (%) | |
| 0 | 7 (16.3) |
| 1 | 0 (0) |
| 2a | 11 (25.6) |
| 2b | 7 (16.3) |
| 3 | 18 (41.8) |
| Etiology (TOAST classification)—no. (%) | |
| Large artery atherosclerosis | 5 (11.6) |
| Cardioembolism | 29 (67.4) |
| Small artery occlusion | 0 (0) |
| Other etiology | 3 (7) |
| Undetermined etiology | 6 (14) |
| Median NIHSS at discharge (IQR) | 13 (8.75–19.5) |
| mRS at day 90a—no. (%) | |
| 0 | 2 (4.7) |
| 1 | 2 (4.7) |
| 2 | 3 (7.0) |
| 3 | 10 (23.2) |
| 4 | 7 (16.3) |
| 5 | 5 (11.6) |
| 6 | 14 (32.6) |
ICA, internal carotid artery; IQR, interquartile range; M1, main branch of medial cerebral artery; M2, distal branch of medial cerebral artery; mRS, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; rtPA, recombinant tissue plasminogen activator; TICI, thrombolysis in cerebral infarction; TOAST, Trial of Org 10172. Data are presented as counts in absolute numbers and percentage, if not stated otherwise.
a
In one patient, follow-up data at day 90 were missing; this value was imputed after the worst-case principle. As a result of rounding, percentages may not exactly sum up to 100%.